12 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Chemfort® 28-day 20 mm Vial Adaptor and 13 mm Convertor

FDA 510(k)
FDA Class 2 ·General Hospital

ACRO BIOTECH LLC RAPID METHAMPHETAMINE URINE TEST; CATALOG# MET001000

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

Digital Blood Pressure Monitor

FDA 510(k)
FDA Class 2 ·Cardiovascular

I-STAT TROPONIN (CTNI) CARTRIDGE

FDA Adverse Event
Malfunction ·ABBOTT POINT OF CARE CANADA LTD.·Product code MMI·August 31, 2011

9617604-2008-00075

FDA Adverse Event
Malfunction ·Product code LGZ·September 12, 2008

LEAD 387460 OCTAD LZ TST STM CMP 60CM

FDA Adverse Event
Malfunction ·NEURO - VILLALBA·Product code LGW·July 29, 2013

CONTOUR PROFILE GEL

FDA Adverse Event
Injury ·MENTOR TEXAS·Product code FTR·July 11, 2018

QUICKIE WHEELCHAIRS

FDA Adverse Event
Malfunction ·SUNRISE MEDICAL (US) LLC·Product code ITI·June 13, 2023

QUICKIE Q300M MINI

FDA Adverse Event
Injury ·SUNRISE MEDICAL (US) LLC·Product code ITI·December 14, 2021

QUICKIE 300M

FDA Adverse Event
Injury ·SUNRISE MEDICAL (US) LLC·Product code ITI·August 14, 2025

QUICKIE WHEELCHAIR

FDA Adverse Event
Malfunction ·SUNRISE MEDICAL (US) LLC·Product code ITI·June 11, 2023

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014